Author's response to Drs. Marasca et al. and Drs. De Vita and Melnik: hidradenitis suppurativa, insulin resistance and mTOR

Affiliations

¹ Division of Internal Medicine, Hospital Universitario Marques de Valdecilla, IDIVAL, University of Cantabria, Avda. de Valdecilla s/n 39008, Santander, Cantabria, Spain.
² Division of Rheumatology, Hospital Universitario Marques de Valdecilla, IDIVAL, University of Cantabria, Avda. de Valdecilla s/n 39008, Santander, Cantabria, Spain.
³ Division of Dermatology, Hospital Universitario Marques de Valdecilla, IDIVAL, University of Cantabria, Avda. de Valdecilla s/n 39008, Santander, Cantabria, Spain.

Comment

J L Hernández et al. J Eur Acad Dermatol Venereol. 2019 Mar.

. 2019 Mar;33(3):e109.

doi: 10.1111/jdv.15273. Epub 2018 Oct 24.

¹ Division of Internal Medicine, Hospital Universitario Marques de Valdecilla, IDIVAL, University of Cantabria, Avda. de Valdecilla s/n 39008, Santander, Cantabria, Spain.
² Division of Rheumatology, Hospital Universitario Marques de Valdecilla, IDIVAL, University of Cantabria, Avda. de Valdecilla s/n 39008, Santander, Cantabria, Spain.
³ Division of Dermatology, Hospital Universitario Marques de Valdecilla, IDIVAL, University of Cantabria, Avda. de Valdecilla s/n 39008, Santander, Cantabria, Spain.

No abstract available

Comment on

Insulin resistance, mTOR and hidradenitis suppurativa.
Marasca C, Balato A, Annunziata MC, Cacciapuoti S, Fabbrocini G. Marasca C, et al. J Eur Acad Dermatol Venereol. 2019 Mar;33(3):e106-e107. doi: 10.1111/jdv.15271. Epub 2018 Oct 24. J Eur Acad Dermatol Venereol. 2019. PMID: 30288789 No abstract available.
mTORC1 at the crossroad of metabolism and immunity in hidradenitis suppurativa.
De Vita V, Melnik BC. De Vita V, et al. J Eur Acad Dermatol Venereol. 2019 Mar;33(3):e107-e109. doi: 10.1111/jdv.15270. Epub 2018 Oct 23. J Eur Acad Dermatol Venereol. 2019. PMID: 30288815 No abstract available.